Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy
- PMID: 6416910
- DOI: 10.2337/diab.32.11.988
Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy
Abstract
Two major metabolic perturbations, increased polyol (sorbitol) pathway activity and reduced tissue myo-inositol content, are induced in peripheral nerve by hyperglycemia. Although they are commonly invoked as alternative biochemical pathogenetic mechanisms for diabetic neuropathy, their possible interrelationship has never been adequately explored. Therefore, we studied the effect of polyol pathway blockade with sorbinil, a specific inhibitor of aldose reductase, on nerve myo-inositol content in acutely streptozotocin-diabetic rats. Sorbinil administration completely prevented the fall in nerve myo-inositol, thereby implicating increased polyol pathway activity as a likely factor in the fall in nerve myo-inositol content in experimental diabetes.
Similar articles
-
Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.Diabetologia. 1983 Oct;25(4):365-71. doi: 10.1007/BF00253203. Diabetologia. 1983. PMID: 6416913
-
Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.Br J Exp Pathol. 1988 Oct;69(5):697-702. Br J Exp Pathol. 1988. PMID: 3143396 Free PMC article.
-
Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.Diabetes. 1984 Aug;33(8):712-6. doi: 10.2337/diab.33.8.712. Diabetes. 1984. PMID: 6086432
-
Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.Drugs. 1986;32 Suppl 2:6-14. doi: 10.2165/00003495-198600322-00004. Drugs. 1986. PMID: 3024950 Review.
-
[Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].Rev Med Interne. 1992 Jan-Feb;13(1):69-79. doi: 10.1016/s0248-8663(05)80015-3. Rev Med Interne. 1992. PMID: 1410879 Review. French.
Cited by
-
Galactose disorders: an overview.J Inherit Metab Dis. 1990;13(4):476-86. doi: 10.1007/BF01799505. J Inherit Metab Dis. 1990. PMID: 2122114 Review.
-
Peripheral nerve function in relation to quality of metabolic control in diabetes.J Neurol. 1987 Jun;234(5):334-6. doi: 10.1007/BF00314290. J Neurol. 1987. PMID: 3612204
-
Measuring brain uptake and incorporation into brain phosphatidylinositol of plasma myo-[2H6]inositol in unanesthetized rats: an approach to estimate in vivo brain phosphatidylinositol turnover.Neurochem Res. 2006 Jun;31(6):759-65. doi: 10.1007/s11064-006-9080-4. Epub 2006 Jun 22. Neurochem Res. 2006. PMID: 16791473
-
Metabolomic profiling relates tianeptine effectiveness with hippocampal GABA, myo-inositol, cholesterol, and fatty acid metabolism restoration in socially isolated rats.Psychopharmacology (Berl). 2022 Sep;239(9):2955-2974. doi: 10.1007/s00213-022-06180-y. Epub 2022 Jul 1. Psychopharmacology (Berl). 2022. PMID: 35776189
-
Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat.Diabetologia. 1992 Sep;35(9):813-7. doi: 10.1007/BF00399926. Diabetologia. 1992. PMID: 1397775
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical